Beijing Science Sun Pharmaceutical's Subsidiary Withdraws Drug Registration Application

Stock News03-20

Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that its subsidiary, Beijing Saier Biological Pharmaceutical Co., Ltd. ("Saier Bio"), recently received a "Notice of Termination of Drug Registration Application" from the National Medical Products Administration. The notice confirms the authority's agreement to Saier Bio's withdrawal of the registration application for its Dapagliflozin Tablets. According to the announcement, Saier Bio submitted the marketing authorization application for Dapagliflozin Tablets to the National Medical Products Administration in March 2025, which was accepted. Due to factors including changes in policies and regulations, further refinement of the application materials is required, leading to the voluntary withdrawal of this application.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1126833963?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 16:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1126833963","market":"us","top_or_hot":-1,"title":"Beijing Science Sun Pharmaceutical's Subsidiary Withdraws Drug Registration Application","media":"Stock News","content":"<p>Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that its subsidiary, Beijing Saier Biological Pharmaceutical Co., Ltd. (\"Saier Bio\"), recently received a \"Notice of Termination of Drug Registration Application\" from the National Medical Products Administration. The notice confirms the authority's agreement to Saier Bio's withdrawal of the registration application for its Dapagliflozin Tablets. According to the announcement, Saier Bio submitted the marketing authorization application for Dapagliflozin Tablets to the National Medical Products Administration in March 2025, which was accepted. Due to factors including changes in policies and regulations, further refinement of the application materials is required, leading to the voluntary withdrawal of this application.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Science Sun Pharmaceutical's Subsidiary Withdraws Drug Registration Application</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Science Sun Pharmaceutical's Subsidiary Withdraws Drug Registration Application\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-20 16:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that its subsidiary, Beijing Saier Biological Pharmaceutical Co., Ltd. (\"Saier Bio\"), recently received a \"Notice of Termination of Drug Registration Application\" from the National Medical Products Administration. The notice confirms the authority's agreement to Saier Bio's withdrawal of the registration application for its Dapagliflozin Tablets. According to the announcement, Saier Bio submitted the marketing authorization application for Dapagliflozin Tablets to the National Medical Products Administration in March 2025, which was accepted. Due to factors including changes in policies and regulations, further refinement of the application materials is required, leading to the voluntary withdrawal of this application.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0028","symbol_name":"国家队","start_time":0,"source_url":"","article_id":"1126833963","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1126833963","pubTimestamp":1773994695,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that its subsidiary, Beijing Saier Biological Pharmaceutical Co., Ltd. (\"Saier Bio\"), recently received a \"Notice of Termination of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300485":"赛升药业","BK0028":"国家队","BK0239":"医药制造","BK0012":"证金概念","BK0046":"生物疫苗"},"translate_title":"北京科学太阳药业子公司撤回药品注册申请","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300485":1},"content_text":"Beijing Science Sun Pharmaceutical Co.,Ltd. (300485.SZ) announced that its subsidiary, Beijing Saier Biological Pharmaceutical Co., Ltd. (\"Saier Bio\"), recently received a \"Notice of Termination of Drug Registration Application\" from the National Medical Products Administration. The notice confirms the authority's agreement to Saier Bio's withdrawal of the registration application for its Dapagliflozin Tablets. According to the announcement, Saier Bio submitted the marketing authorization application for Dapagliflozin Tablets to the National Medical Products Administration in March 2025, which was accepted. Due to factors including changes in policies and regulations, further refinement of the application materials is required, leading to the voluntary withdrawal of this application.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1126833963","isCrawlerRequest":true}